Can you still get a good price for Oportun Financial Corp (OPRT) Shares at this point?

While Oportun Financial Corp has underperformed by -7.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OPRT rose by 83.25%, with highs and lows ranging from $9.24 to $2.37, whereas the simple moving average jumped by 46.73% in the last 200 days.

On June 12, 2025, Stephens started tracking Oportun Financial Corp (NASDAQ: OPRT) recommending Overweight. A report published by BTIG Research on March 05, 2025, Initiated its previous ‘Buy’ rating for OPRT. Jefferies March 14, 2024d the rating to Hold on March 14, 2024, and set its price target from $9 to $3.50. JP Morgan October 17, 2023d its ‘Overweight’ rating to ‘Neutral’ for OPRT, as published in its report on October 17, 2023. B. Riley Securities’s report from June 29, 2023 suggests a price prediction of $9 for OPRT shares, giving the stock a ‘Buy’ rating. BTIG Research also rated the stock as ‘Buy’.

Analysis of Oportun Financial Corp (OPRT)

Further, the quarter-over-quarter decrease in sales is -5.82%, showing a negative trend in the upcoming months.

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Oportun Financial Corp’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -11.37% is sufficient for you to turn a profit off your investment.

As an indicator of volatility for any stock, average volume can also be very valuable, and OPRT is recording an average volume of 506.59K. On a monthly basis, the volatility of the stock is set at 7.56%, whereas on a weekly basis, it is put at 9.03%, with a loss of -0.70% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.29, showing growth from the present price of $7.11, which can serve as yet another indication of whether OPRT is worth investing in or should be passed over.

How Do You Analyze Oportun Financial Corp Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 21.14%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 57.41% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

OPRT shares are owned by institutional investors to the tune of 57.41% at present.

Hot this week

Nano X Imaging Ltd (NNOX) stock analysis: A simple moving average approach

While Nano X Imaging Ltd has overperformed by 2.15%,...

FTAI Aviation Ltd (FTAI)’s highs and lows: A closer look at its stock price fluctuations

While FTAI Aviation Ltd has underperformed by -1.55%, investors...

A year in review: QXO Inc (QXO)’s performance in the last year

While QXO Inc has underperformed by -0.14%, investors are...

EXK underperforms with a -7.63 decrease in share price

While Endeavour Silver Corp has underperformed by -7.63%, investors...

Technical analysis of Douglas Elliman Inc (DOUG) stock chart patterns

While Douglas Elliman Inc has overperformed by 2.94%, investors...

Topics

Nano X Imaging Ltd (NNOX) stock analysis: A simple moving average approach

While Nano X Imaging Ltd has overperformed by 2.15%,...

FTAI Aviation Ltd (FTAI)’s highs and lows: A closer look at its stock price fluctuations

While FTAI Aviation Ltd has underperformed by -1.55%, investors...

A year in review: QXO Inc (QXO)’s performance in the last year

While QXO Inc has underperformed by -0.14%, investors are...

EXK underperforms with a -7.63 decrease in share price

While Endeavour Silver Corp has underperformed by -7.63%, investors...

Technical analysis of Douglas Elliman Inc (DOUG) stock chart patterns

While Douglas Elliman Inc has overperformed by 2.94%, investors...

A stock that deserves closer examination: Anavex Life Sciences Corporation (AVXL)

While Anavex Life Sciences Corporation has overperformed by 2.00%,...

Aclaris Therapeutics Inc (ACRS) deserves deeper analysis

While Aclaris Therapeutics Inc has underperformed by -0.68%, investors...

Was Terns Pharmaceuticals Inc (TERN)’s session last reading good?

While Terns Pharmaceuticals Inc has overperformed by 13.25%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.